p53: at the crossroads of molecular carcinogenesis and risk assessment - PubMed (original) (raw)

Review

. 1993 Dec 24;262(5142):1980-1.

doi: 10.1126/science.8266092.

Affiliations

• PMID: 8266092
• DOI: 10.1126/science.8266092

Review

p53: at the crossroads of molecular carcinogenesis and risk assessment

C C Harris. Science. 1993.

No abstract available

PubMed Disclaimer

Similar articles

• p53: at the crossroads of molecular carcinogenesis and molecular epidemiology.
  Harris CC. Harris CC. J Investig Dermatol Symp Proc. 1996 Apr;1(2):115-8. J Investig Dermatol Symp Proc. 1996. PMID: 9627703 Review.
• p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.
  Hussain SP, Hollstein MH, Harris CC. Hussain SP, et al. Ann N Y Acad Sci. 2000;919:79-85. doi: 10.1111/j.1749-6632.2000.tb06870.x. Ann N Y Acad Sci. 2000. PMID: 11083100
• p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment.
  Harris CC. Harris CC. Environ Health Perspect. 1996 May;104 Suppl 3(Suppl 3):435-9. doi: 10.1289/ehp.96104s3435. Environ Health Perspect. 1996. PMID: 8781359 Free PMC article. Review.
• p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.
  Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu SM, Kusters I, Resau JH, Trump BF, Lane DP, et al. Bennett WP, et al. Cancer Res. 1992 Nov 1;52(21):6092-7. Cancer Res. 1992. PMID: 1394236
• The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype.
  Levine AJ, Wu MC, Chang A, Silver A, Attiyeh EF, Lin J, Epstein CB. Levine AJ, et al. Ann N Y Acad Sci. 1995 Sep 30;768:111-28. doi: 10.1111/j.1749-6632.1995.tb12115.x. Ann N Y Acad Sci. 1995. PMID: 8526340 Review. No abstract available.

Cited by

• Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation.
  Wu D, Ozaki T, Yoshihara Y, Kubo N, Nakagawara A. Wu D, et al. J Biol Chem. 2013 Jan 11;288(2):1353-64. doi: 10.1074/jbc.M112.402594. Epub 2012 Nov 12. J Biol Chem. 2013. PMID: 23148227 Free PMC article.
• Applications of new technology in molecular epidemiology and their relevance to occupational medicine.
  Koh D, Seow A, Ong CN. Koh D, et al. Occup Environ Med. 1999 Nov;56(11):725-9. doi: 10.1136/oem.56.11.725. Occup Environ Med. 1999. PMID: 10658556 Free PMC article.
• p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain.
  Bakalkin G, Selivanova G, Yakovleva T, Kiseleva E, Kashuba E, Magnusson KP, Szekely L, Klein G, Terenius L, Wiman KG. Bakalkin G, et al. Nucleic Acids Res. 1995 Feb 11;23(3):362-9. doi: 10.1093/nar/23.3.362. Nucleic Acids Res. 1995. PMID: 7885831 Free PMC article.
• Gene regulation by temperature-sensitive p53 mutants: identification of p53 response genes.
  Buckbinder L, Talbott R, Seizinger BR, Kley N. Buckbinder L, et al. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10640-4. doi: 10.1073/pnas.91.22.10640. Proc Natl Acad Sci U S A. 1994. PMID: 7938006 Free PMC article.
• Physical activity and cancer prevention : pathways and targets for intervention.
  Rogers CJ, Colbert LH, Greiner JW, Perkins SN, Hursting SD. Rogers CJ, et al. Sports Med. 2008;38(4):271-96. doi: 10.2165/00007256-200838040-00002. Sports Med. 2008. PMID: 18348589 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal